Cargando…

Long-term effects and significant adverse drug reactions (ADRs) associated with the use of gonadotropin-releasing hormone analogs (GnRHa) for central precocious puberty: a brief review of literature

Central precocious puberty (CPP) is defined as an early pubertal development that occurs before the age of 9 years in boys and 8 years in girls. It results from premature activation of the hypothalamic-pituitary-gonadal axis. Gonadotropin-releasing hormone agonists (GnRHa) have been the gold standar...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Sanctis, Vincenzo, Soliman, Ashraf T, Di Maio, Salvatore, Soliman, Nada, Elsedfy, Heba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2019
Materias:	Review: Pediatric Endocrinology Update - Section
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233750/ https://www.ncbi.nlm.nih.gov/pubmed/31580327 http://dx.doi.org/10.23750/abm.v90i3.8736

Ejemplares similares

Treatment of central precocious puberty using low dose GnRH analogs (GnRHa)
por: Jahagirdar, Rahul, et al.
Publicado: (2015)

A single sample GnRHa stimulation test in the diagnosis of precocious puberty
por: Yazdani, Parvin, et al.
Publicado: (2012)

Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty
por: Lewis, Katherine A, et al.
Publicado: (2009)

GnRHa/Stanozolol Combined Therapy Maintains Normal Bone Growth in Central Precocious Puberty
por: Zhu, Shunye, et al.
Publicado: (2021)

The Efficacy of GnRHa Alone or in Combination with rhGH for the Treatment of Chinese Children with Central Precocious Puberty
por: Wang, Mengjie, et al.
Publicado: (2016)

Growth, bone maturation and ovarian size in girls with early and fast puberty (EFP) and effects of three years treatment with GnRH analogue (GnRHa)
por: Alaaraj, Nada, et al.
Publicado: (2021)

Response of South Indian girls with central precocious puberty to gonadotrophin analogue (GnRHa) therapy – a single center experience
por: Selvaraj, Meghana, et al.
Publicado: (2021)

Fertility preservation and GnRHa for chemotherapy: debate
por: Blumenfeld, Zeev
Publicado: (2014)

GnRHa trigger—the story of the ugly duckling
por: Humaidan, Peter, et al.
Publicado: (2023)

The Luteal Phase after GnRHa Trigger-Understanding An Enigma
por: Leth-Moller, Kathrine, et al.
Publicado: (2014)

Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells
por: Luo, Xiaoping, et al.
Publicado: (2003)

Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone
por: Agarwal, Sanjay K., et al.
Publicado: (2015)

Development of Hip Bone Geometry in Transgender Adolescents Resembles the Experienced Gender if GnRHa Treatment Is Started in Early, but Not Late, Puberty
por: van der Loos, Maria A T C, et al.
Publicado: (2021)

Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study
por: Bruzzi, Patrizia, et al.
Publicado: (2017)

Comparison of Clinical Efficacy between a Single Administration of Long-Acting Gonadotrophin-Releasing Hormone Agonist (GnRHa) and Daily Administrations of Short-Acting GnRHa in In Vitro Fertilization-Embryo Transfer Cycles
por: Cheon, Kang Woo, et al.
Publicado: (2008)

Retraction Note to: Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells
por: Luo, Xiaoping, et al.
Publicado: (2015)

Perspectives on the co-treatment with GnRHa in female patients undergoing hematopoietic stem cell transplantation
por: Cima, Luminita Nicoleta, et al.
Publicado: (2017)

Curative GnRHa treatment has an unexpected repressive effect on Sertoli cell specific genes
por: Gegenschatz-Schmid, Katharina, et al.
Publicado: (2018)

Empty Follicle Syndrome Following GnRHa Trigger in PCOS Patients Undergoing IVF Cycles
por: Deepika, Krishna, et al.
Publicado: (2018)

GnRHa Before Single-Port Laparoscopic Hysterectomy in a Large Barrel-Shaped Uterus
por: Torng, Pao-Ling, et al.
Publicado: (2019)

Testicular expression of long non–coding RNAs is affected by curative GnRHa treatment of cryptorchidism
por: Hadziselimovic, Faruk, et al.
Publicado: (2019)

Benefits from the first year of GnRHa therapy in boys with idiopathic central precocious puberty when initiating treatment after age 9 years: findings from a real-world retrospective study
por: Ni, Ming-ming, et al.
Publicado: (2022)

GnRHa protects the ovarian reserve by reducing endoplasmic reticulum stress during cyclophosphamide-based chemotherapy
por: Li, Xiaolin, et al.
Publicado: (2021)

Challenges in monitoring GnRH analog treatment in central precocious puberty
por: Latronico, Ana Claudia
Publicado: (2020)

GnRHa for Ovarian Protection and the Association between AMH and Ovarian Function during Adjuvant Chemotherapy for Breast Cancer
por: Zhong, Ying, et al.
Publicado: (2019)

Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas
por: Khan, Khaleque N., et al.
Publicado: (2020)

GnRHa as a treatment for letrozole-resistant recurrent adult granulosa cell tumors: A case report
por: Zhuang, Yuan, et al.
Publicado: (2021)

Effect of recombinant LH supplementation timing on clinical pregnancy outcome in long-acting GnRHa downregulated cycles
por: Huang, Chenyang, et al.
Publicado: (2022)

Pituitary suppression with a GnRHa short protocol in an alternate day schedule associated with rhCG microdoses
por: Rodrigues, Rosane S., et al.
Publicado: (2014)

Just as Tall on Testosterone; a Neutral to Positive Effect on Adult Height of GnRHa and Testosterone in Trans Boys
por: Willemsen, Lieve Anne, et al.
Publicado: (2022)

Effects of GnRHa treatment during vitellogenesis on the reproductive physiology of thermally challenged female Atlantic salmon (Salmo salar)
por: Anderson, Kelli, et al.
Publicado: (2017)

Pre-treatment with GnRHa or ulipristal acetate prior to laparoscopic and laparotomic myomectomy: A systematic review and meta-analysis
por: de Milliano, Inge, et al.
Publicado: (2017)

Effect of Exogenous Luteinizing Hormone (LH) Supplementation on Clinical Pregnancy of Patients Receiving Long-Acting Gonadotropin-Releasing Hormone Agonist (GnRHa) Cycles: A Retrospective Cohort Study
por: Huang, Chenyang, et al.
Publicado: (2022)

Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty
por: Kim, Eun Young
Publicado: (2015)

Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States
por: Popovic, Jadranka, et al.
Publicado: (2022)

Comparison Between PPOS and GnRHa-Long Protocol in Clinical Outcome with the First IVF/ICSI Cycle: A Randomized Clinical Trial
por: Xi, Qianwen, et al.
Publicado: (2020)

OR15-01 Blockers and Bones: Loss of Absolute Bone Mineral Density Is Common in Trans- and Gender- Diverse Adolescents Treated with GnRHa
por: Ferguson, Grant, et al.
Publicado: (2020)

Serum aminoterminal proctype natriuretic peptide in girls with idiopathic central precocious puberty during GNRHA treatment
por: Chen, Qiu-li, et al.
Publicado: (2013)

Clinical and Laboratory Parameters of Gonadotropin-Releasing Hormone Analog Treatment Effectiveness in Children with Precocious Puberty
por: Fujita, Lívia Grimaldi Abud, et al.
Publicado: (2019)

A Case of Nonalcoholic Steatohepatitis in Central Precocious Puberty Aggravated by Gonadotropin-releasing Hormone Analog
por: Sasaki, Yoshiaki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4rjc3thmvpj1f80o97oo8i9k97